News

2016 Jan 25

Adjuvant oxaliplatin reduces colon cancer recurrence, deaths

Adding oxaliplatin to fluoropyrimidine-based adjuvant chemotherapy significantly reduces the risk of recurrence of colon cancer, according to Manish Shah, M.D. Read more

2016 Jan 25

Imaging experts create “cancer spray” to illuminate tumors for surgeons

Ching-Hsuan Tung, Ph.D., has developed a fluorescent “cancer spray” that can be applied to the ovaries and other organs during surgery to create a luminous outline of cancerous cell clusters. Read more

2016 Jan 25

Link between prostate protein and adrenal tumors provides new hope for rare cancer

New prostate cancer treatments could provide hope for those with a rare form of endocrine cancer, according to findings from a team of Meyer researchers led by Thomas Fahey III, M.D. Read more

2016 Jan 25

From tracer to treatment: Radiopharmaceuticals home in on hard-to-detect cancers

John Babich, Ph.D., has developed a protocol that combines radiopharmaceuticals and PET scans to improve detection and patient management in prostate cancer. Read more

Video of Manish Shah, M.D., discussing gastric cancer in Asian populations

2016 Jan 22

Does the Asian population differ from the western populations in regards to gastric cancers

Manish Shah, M.D., speaks about gastric cancer among the Asian population at ASCO GI 2016. Read more

Claudia Fischbach-Teschl and Cynthia Reinhart-King

2016 Jan 21

Ithaca professors elected as AIMBE fellows

Claudia Fischbach-Teschl, Ph.D., and Cynthia Reinhart-King, Ph.D., have been elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows. Read more

David Li, MD, PhD, and David C. Madoff, MD, FSIR, FACR

2016 Jan 21

Interventional Oncology as the Fourth Pillar of Cancer Care

David Madoff, M.D., and David Li, M.D., Ph.D., elucidate the role and potential of interventional radiologists in cancer care. Read more

2016 Jan 21

FDA Approves Carfilzomib Combo for Relapsed Multiple Myeloma

Ruben Niesvizky, M.D., discusses a newly approved combination therapy for multiple myeloma. Read more

2016 Jan 21

Chemotherapy regimens for patients with advanced gastric cancer

Holly G. Prigerson, Ph.D. discusses chemotherapy regimens for patients with advanced gastric cancer. Read more

2016 Jan 21

Cantley, Rubin among "most influential scientific minds"

Lewis Cantley, Ph.D., and Mark Rubin, M.D., have made a Thomson-Reuters list of influential scientists. Read more

2016 Jan 20

Protein critical to cell survival also promotes metastasis independently

A protein that normally exists in the mitochondria of healthy cells appears to travel to the nucleus of cancer cells and promote metastasis, according to a study by Nancy Du, Ph.D. Read more

2016 Jan 19

Dying docs opt for less aggressive end-of-life care

Doctors facing death may be less likely to seek surgery or visit the intensive-care unit during the last six months of their lives, according to a study by Holly Prigerson, Ph.D. Read more

2016 Jan 19

Prognostic factors and the impact of new therapies for CLL

Richard Furman, M.D., discusses therapies for chronic lymphocytic leukemia. Read more

2016 Jan 18

Expert discusses emerging agents and the future of follicular lymphoma

When it comes to treating follicular lymphoma, oncologists must carefully consider treatments, says John P. Leonard, M.D. Read more

Patient Irene Price with Dr. David Nanus

2016 Jan 18

Gene sequencing effort helps pinpoint cancer treatments

Precision medicine is helping cancer patients at Weill Cornell Medicine. Read more

2016 Jan 17

Moonshot to Cure Cancer

Dean Laurie Glimcher, M.D., talks about scientific discoveries combating cancer. Read more

2016 Jan 14

Privacy in the post-genomic era: Impossible

Chris Mason, Ph.D., discusses consumer genomics at a healthcare conference. Read more

Lewis Cantley receiving the Wolf Prize from Israeli president Reuven Rivlin

2016 Jan 14

Cantley among 7 Wolf Prize laureates

Meyer director Lewis Cantley, Ph.D, has been awarded "Israel's Nobel Prize." Read more

2016 Jan 14

Is the cure for cancer real or rhetoric?

Harold Varmus, M.D., comments on Vice President Joe Biden's "moonshot" effort to cure cancer. Read more

2016 Jan 13

Getting a GRASP on the R01 Funding Process

The new Grant Review and Support Program (GRASP) at Weill Cornell Medicine is training assistant professor and instructor level investigators to successfully submit their first National Institutes of Health (NIH) R01 proposal. Read more

News

Adjuvant oxaliplatin reduces colon cancer recurrence, deaths

Imaging experts create “cancer spray” to illuminate tumors for surgeons

Link between prostate protein and adrenal tumors provides new hope for rare cancer

From tracer to treatment: Radiopharmaceuticals home in on hard-to-detect cancers

Does the Asian population differ from the western populations in regards to gastric cancers

Ithaca professors elected as AIMBE fellows

Interventional Oncology as the Fourth Pillar of Cancer Care

FDA Approves Carfilzomib Combo for Relapsed Multiple Myeloma

Chemotherapy regimens for patients with advanced gastric cancer

Cantley, Rubin among "most influential scientific minds"

Protein critical to cell survival also promotes metastasis independently

Dying docs opt for less aggressive end-of-life care

Prognostic factors and the impact of new therapies for CLL

Expert discusses emerging agents and the future of follicular lymphoma

Gene sequencing effort helps pinpoint cancer treatments

Moonshot to Cure Cancer

Privacy in the post-genomic era: Impossible

Cantley among 7 Wolf Prize laureates

Is the cure for cancer real or rhetoric?

Getting a GRASP on the R01 Funding Process

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters